chelerythrine has been researched along with Glioblastoma in 1 studies
chelerythrine : A benzophenanthridine alkaloid isolated from the root of Zanthoxylum simulans, Chelidonium majus L., and other Papaveraceae.
Glioblastoma: A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhu, M | 1 |
| Niu, J | 1 |
| Jiang, J | 1 |
| Dong, T | 1 |
| Chen, Y | 1 |
| Yang, X | 1 |
| Liu, P | 1 |
1 other study available for chelerythrine and Glioblastoma
| Article | Year |
|---|---|
Chelerythrine inhibits the progression of glioblastoma by suppressing the TGFB1-ERK1/2/Smad2/3-Snail/ZEB1 signaling pathway.
Topics: Animals; Antineoplastic Agents; Benzophenanthridines; Brain Neoplasms; Cell Line, Tumor; Cell Surviv | 2022 |